Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Miromatrix Medical Inc (NQ: MIRO ) N/A UNCHANGED Last Price Updated: 4:00 PM EST, Dec 12, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Miromatrix Medical Inc < Previous 1 2 Next > United Therapeutics and Miromatrix Medical Announce Completion of Tender Offer and Merger December 13, 2023 From United Therapeutics Corporation Via Business Wire United Therapeutics and Miromatrix Medical Announce Successful Tender Offer December 12, 2023 From United Therapeutics Corporation Via Business Wire MIROMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Miromatrix Medical Inc. - MIRO November 15, 2023 From Kahn Swick & Foti, LLC Via Business Wire Miromatrix Medical Inc. (NASDAQ: MIRO) Near the Top of Equities by Percentage Gain on 10/30 October 30, 2023 Via Investor Brand Network Miromatrix Reports Third Quarter 2023 Results November 14, 2023 From Miromatrix Medical Inc. Via GlobeNewswire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC) November 13, 2023 From Brodsky & Smith LLC Via GlobeNewswire MIROMATRIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Miromatrix Medical Inc. - MIRO November 01, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC) October 30, 2023 From Brodsky & Smith LLC Via GlobeNewswire MIRO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Miromatrix Medical Inc. Is Fair to Shareholders October 30, 2023 From Halper Sadeh LLC Via Business Wire United Therapeutics to Acquire Miromatrix Medical October 30, 2023 From Miromatrix Medical Inc. Via GlobeNewswire United Therapeutics to Acquire Miromatrix Medical October 30, 2023 From United Therapeutics Corporation Via Business Wire Miromatrix to Present at the 2023 ISODP Organ Donation Congress October 11, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Mesa October 05, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference September 06, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop September 05, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update August 14, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix to Report Second Quarter 2023 Financial Results July 25, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award July 13, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D June 01, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Presenting at the 2023 American Transplant Congress May 30, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference May 30, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update May 11, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix to Report First Quarter 2023 Financial Results April 27, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med April 10, 2023 From Miromatrix Medical Inc. Via GlobeNewswire CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation April 05, 2023 From CareDx, Inc. Via Business Wire CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation April 05, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update March 31, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results March 15, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock March 07, 2023 From Miromatrix Medical Inc. Via GlobeNewswire Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock March 07, 2023 From Miromatrix Medical Inc. Via GlobeNewswire < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.